T80.22
Acute infection following transfusion, infusion, or injection of blood and blood products
Clinical Classification Guidelines
Medical Intelligence & Overview
Acute infection following transfusion, infusion, or injection of blood and blood products is a condition that occurs when an infection develops shortly after receiving blood-related treatments. This can happen during or after procedures like blood transfusions, infusions, or injections of blood products. Though advancements in medical practices have made blood transfusions safer, there remains a small risk of infections which can lead to serious health complications unless promptly recognized and managed.
Causes & Symptoms
Clinical Causes: Contamination of blood or blood products with infectious agents such as bacteria, viruses, or parasites Poor sterilization or handling procedures during collection, processing, or administration of blood products Use of contaminated medical equipment during transfusions or injections Recipient's immune response reacting to transfused blood components, leading to infection-like symptoms Presence of undetected infections in donor blood that are transmitted during transfusion
Key Symptoms: Fever and chills Signs of sepsis, such as low blood pressure, rapid heartbeat, or confusion Skin rashes or allergic reactions at injection site General malaise and fatigue Nausea or vomiting Breathing difficulties in severe cases Pain or swelling at the site of transfusion or injection
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a combination of clinical assessment and laboratory investigations. Healthcare providers may perform:
Treatment Protocols: Management typically includes:
Clinical Advice & FAQs
Billing Guidance
Is T80.22 a billable ICD-10 code?
Yes, T80.22 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report T80.22?
Clinical documentation must specify the nature of Acute infection following transfusion, infusion, or injection of blood and blood products and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
